Member access

4-Traders Homepage  >  Shares  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)

13
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 02/27 05:25:22 pm
35.9650 EUR   +1.37%
2014DIASORIN SPA : quaterly earnings release
2014 DIASORIN : launches the stool test for Adenovirus on LIAISON
2014 DIASORIN : The Board of Directors approves the results for H1'14
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
35.66(c) 35.59(c) 35.62(c) 35.48(c) 36.08(c) Last
49 635 38 174 31 648 159 414 59 078 Volume
+0.42% -0.20% +0.08% -0.39% +1.69% Change
More quotes
Company
DiaSorin SpA engages in the development, production, and marketing reagent kits for in vitro diagnostics.It operates through the Immunodiagnostics and Molecular Diagnostics segments.The Immunodiagnostics segment manufactures and distributes immunoreagent kits based on chemiluminescence,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 445 M
EBIT 2014 134 M
Net income 2014 84,5 M
Finance 2014 91,1 M
Yield 2014 1,44%
Sales 2015 477 M
EBIT 2015 147 M
Net income 2015 93,7 M
Finance 2015 127 M
Yield 2015 1,58%
PER 2014 22,82
PER 2015 20,61
EV / Sales 2014 4,25x
EV / Sales 2015 3,90x
Capitalization 1 985 M
More Financials
Latest news on DIASORIN SPA
01/13 DIASORIN : Sources Sought Notice - 66-- 501-15-3-085-0038 Diasorin Analyzer, Rea..
2014DIASORIN SPA : quaterly earnings release
2014 DIASORIN : launches the stool test for Adenovirus on LIAISON
2014 DIASORIN : Announces New Webinar in Their Annual Vitamin D Series
2014 DIASORIN : The Board of Directors approves the results for H1'14
2014 DIASORIN : Confirms its eligibility for the pea-pme
2014 DIASORIN : launches the test for Vitamin D 1,25 on LIAISON
2014 DIASORIN SPA : ex-dividend day for annual dividend
More news
Sector news Diagnostic & Testing Substances
06:04p CAREFUSION : MedMined® Surveillance Advisor Wins KLAS Category Leader Award
01:13p MEDTRONIC : EVP & President Michael J. Coyle to Speak at Cowen Healthcare Confer..
09:11a ST JUDE MEDICAL : to Present at the Barclays Global Healthcare Conference
Plus d'actualités du secteur Diagnostic & Testing Substances


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF